Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamate-Glutamine Cycling in Cocaine Abstinence
NCT02124941Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2014
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetylcysteine in cocaine dependence (2 arms), sponsored by Yale University. Primary endpoint: Glutamate and Glutamate/Glutamine ratios at 4 weeks. Started Feb 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT02124941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124941.